Your browser doesn't support javascript.
loading
Outcome of secondary acute myeloid leukemia treated with hypomethylating agent plus venetoclax (HMA-Ven) or liposomal daunorubicin-cytarabine (CPX-351).
Salhotra, Amandeep; Aribi, Ahmed; Ngo, Dat; Zhang, Jianying; Sandhu, Karamjeet; Al-Malki, Monzr; Ali, Haris; Koller, Paul; Arslan, Shukaib; Budde, Elizabeth; Khaled, Samer; Dadwal, Sanjeet; Snyder, David S; Artz, Andrew; Forman, Stephen; Nakamura, Ryotaro; Stein, Anthony; Marcucci, Guido; Aldoss, Ibrahim; Pullarkat, Vinod.
Afiliação
  • Salhotra A; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Aribi A; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Ngo D; Department of Clinical Pharmacology, City of Hope National Medical Center, Duarte, California.
  • Zhang J; Department of Information Sciences, City of Hope National Medical Center, Duarte, California.
  • Sandhu K; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Al-Malki M; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Ali H; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Koller P; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Arslan S; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Budde E; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Khaled S; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Dadwal S; Division of Infectious Disease, City of Hope National Medical Center, Duarte, California.
  • Snyder DS; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Artz A; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Forman S; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Nakamura R; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Stein A; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Marcucci G; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Aldoss I; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Pullarkat V; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
Am J Hematol ; 96(6): E196-E200, 2021 06 01.
Article em En | MEDLINE | ID: mdl-33719090
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Segunda Neoplasia Primária Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Segunda Neoplasia Primária Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2021 Tipo de documento: Article